PAD Profile : Alteplase - Thrombolysis

PLEASE NOTE : This is a development system.

For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.

You are here : Home > PAD Profile : Alteplase - Thrombolysis

Keywords :

fibrinolytics, thrombolytic therapy, acute ischaemic stroke, acute myocardial infarction, MI, pulmonary embolism, PE

Brand Names Include :

Actilyse

Traffic Light Status

Status :

Red

Formulations :

Trust Alignment :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

BNF NICE SPC

NFD1

Comments :

No comments returned.

Documents :

No guidelines returned.

Type

Document

Review Date

NICE Technology Appraisal

Date

Committee Name

Narrative

24 October 2012

Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)

NICE guidance discussed at the PCN. Alteplase is not a payment by results excluded drug and should be funded from within tariff by the acute trusts.

02. Cardiovascular System

02.10.02. Fibrinolytic drugs